Literature DB >> 23244761

Shaping the p53 response with nucleoporins.

Melanie L Yarbrough1, Michael A White, Beatriz M A Fontoura.   

Abstract

In this issue, Singer et al. (2012) reveal that the nucleoporin Nup98 supports adaptation to genotoxic stress by protecting specific p53-induced mRNAs from exosome-dependent degradation, suggesting that wild-type Nup98 may possess tumor suppressor function.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID: 23244761      PMCID: PMC3597242          DOI: 10.1016/j.molcel.2012.11.027

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  10 in total

1.  Role of nucleoporin induction in releasing an mRNA nuclear export block.

Authors:  Jost Enninga; David E Levy; Günter Blobel; Beatriz M A Fontoura
Journal:  Science       Date:  2002-01-24       Impact factor: 47.728

Review 2.  Gene positioning and expression.

Authors:  Defne Egecioglu; Jason H Brickner
Journal:  Curr Opin Cell Biol       Date:  2011-02-01       Impact factor: 8.382

3.  Nup98 is a mobile nucleoporin with transcription-dependent dynamics.

Authors:  Eric R Griffis; Nihal Altan; Jennifer Lippincott-Schwartz; Maureen A Powers
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

4.  The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation.

Authors:  Karthik B Jeganathan; Liviu Malureanu; Jan M van Deursen
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

5.  The vertebrate GLFG nucleoporin, Nup98, is an essential component of multiple RNA export pathways.

Authors:  M A Powers; D J Forbes; J E Dahlberg; E Lund
Journal:  J Cell Biol       Date:  1997-01-27       Impact factor: 10.539

Review 6.  Nuclear pore proteins and cancer.

Authors:  Songli Xu; Maureen A Powers
Journal:  Semin Cell Dev Biol       Date:  2009-03-18       Impact factor: 7.727

7.  Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.

Authors:  Stephan Singer; Ruiying Zhao; Anthony M Barsotti; Anette Ouwehand; Mina Fazollahi; Elias Coutavas; Kai Breuhahn; Olaf Neumann; Thomas Longerich; Tobias Pusterla; Maureen A Powers; Keith M Giles; Peter J Leedman; Jochen Hess; David Grunwald; Harmen J Bussemaker; Robert H Singer; Peter Schirmacher; Carol Prives
Journal:  Mol Cell       Date:  2012-10-24       Impact factor: 17.970

8.  The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation.

Authors:  Timothy A Bolger; Andrew W Folkmann; Elizabeth J Tran; Susan R Wente
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

9.  Nup98 regulates bipolar spindle assembly through association with microtubules and opposition of MCAK.

Authors:  Marie K Cross; Maureen A Powers
Journal:  Mol Biol Cell       Date:  2011-01-05       Impact factor: 4.138

10.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.

Authors:  Gang G Wang; Jikui Song; Zhanxin Wang; Holger L Dormann; Fabio Casadio; Haitao Li; Jun-Li Luo; Dinshaw J Patel; C David Allis
Journal:  Nature       Date:  2009-06-11       Impact factor: 49.962

  10 in total
  3 in total

Review 1.  Nuclear trafficking in health and disease.

Authors:  Amir Mor; Michael A White; Beatriz M A Fontoura
Journal:  Curr Opin Cell Biol       Date:  2014-02-11       Impact factor: 8.382

2.  Bridge-Induced Translocation between NUP145 and TOP2 Yeast Genes Models the Genetic Fusion between the Human Orthologs Associated With Acute Myeloid Leukemia.

Authors:  Valentina Tosato; Nicole West; Jan Zrimec; Dmitri V Nikitin; Giannino Del Sal; Roberto Marano; Michael Breitenbach; Carlo V Bruschi
Journal:  Front Oncol       Date:  2017-09-29       Impact factor: 6.244

Review 3.  Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export.

Authors:  Sharon K Kuss; Miguel A Mata; Liang Zhang; Beatriz M A Fontoura
Journal:  Viruses       Date:  2013-07-18       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.